Last $15.66 HKD
Change Today -0.16 / -1.01%
Volume 470.9K
963 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

bloomage biotechnology (963) Snapshot

Open
$15.82
Previous Close
$15.82
Day High
$16.12
Day Low
$15.64
52 Week High
03/13/14 - $27.80
52 Week Low
09/9/13 - $11.82
Market Cap
5.2B
Average Volume 10 Days
262.5K
EPS TTM
$0.32
Shares Outstanding
332.0M
EX-Date
05/30/14
P/E TM
39.4x
Dividend
$0.02
Dividend Yield
0.12%
Current Stock Chart for BLOOMAGE BIOTECHNOLOGY (963)

Related News

No related news articles were found.

bloomage biotechnology (963) Related Businessweek News

No Related Businessweek News Found

bloomage biotechnology (963) Details

Bloomage BioTechnology Corporation Limited, an investment holding company, manufactures and sells bio-chemical products. The company produces and sells hyaluronic acid (HA) raw materials used in pharmaceutical, cosmetic, and healthcare products; and develops HA end products comprising hyaluronan soft tissue filling gel and medical sodium hyaluronate gel for ophthalmologic use, as well as bone products for intra-articular injection. It provides HA raw materials in injection, eye drop, cosmetic, and food grades, as well as in HA oligosaccharide grade. The company also develops, distributes, and sells medical devices, as well as sells beauty products. Bloomage BioTechnology Corporation Limited sells its products primarily in the People’s Republic of China, Asia, and the Americas. The company was founded in 2003 and is based in Jinan, the People’s Republic of China.

549 Employees
Last Reported Date: 08/20/14
Founded in 2000

bloomage biotechnology (963) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: CNY655.0K
Executive Director and Member of Nomination C...
Total Annual Compensation: CNY814.0K
Executive Director
Total Annual Compensation: CNY430.0K
Compensation as of Fiscal Year 2013.

bloomage biotechnology (963) Key Developments

Bloomage BioTechnology Corporation Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

Bloomage BioTechnology Corporation Limited reported unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, turnover was RMB 243.847 million against RMB 185.330 million a year ago. Profit from operations was RMB 109.016 million against RMB 94.442 million a year ago. Profit before taxation was RMB 103.954 million against RMB 89.640 million a year ago. Profit attributable to equity shareholders of the company was RMB 83.764 million or RMB 0.242 per diluted share against RMB 73.415 million or RMB 0.224 per diluted share a year ago.

Bloomage BioTechnology Corporation Limited to Report First Half, 2014 Results on Aug 20, 2014

Bloomage BioTechnology Corporation Limited announced that they will report first half, 2014 results on Aug 20, 2014

Bloomage BioTechnology Corporation Limited, Board Meeting, Aug 20, 2014

Bloomage BioTechnology Corporation Limited, Board Meeting, Aug 20, 2014. Agenda: To consider and approve the unaudited interim results and announcement of the company and its subsidiaries for the six months ended June 30, 2014 and the payment of an interim dividend, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
963:HK $15.66 HKD -0.16

963 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 963.
View Industry Companies
 

Industry Analysis

963

Industry Average

Valuation 963 Industry Range
Price/Earnings 41.6x
Price/Sales 9.7x
Price/Book 6.4x
Price/Cash Flow 40.1x
TEV/Sales 9.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLOOMAGE BIOTECHNOLOGY, please visit www.bloomagebio-tech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.